Earnings Feed
Start Free
Home/Filings/4/0001097264-05-000005
4//SEC Filing

ALLOS THERAPEUTICS INC 4

Accession 0001097264-05-000005

CIK 0001097264operating
View on SEC.govCompany Profile

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 5:13 PM ET

Size

19.0 KB

Accession

0001097264-05-000005

Insider Transaction Report

Form 4
Period: 2005-02-07
ALLOS THERAPEUTICS INCALTH
HART MICHAEL E
DirectorChief Executive Officer
Transactions
  • Award

    Stock Options (Right to buy)

    2005-02-07$2.37/sh+40,000$94,800→ 40,000 total
    Exercise: $2.37From: 2006-02-07Exp: 2015-02-07→ Common Stock (40,000 underlying)
Holdings

  • Stock Options (Right to buy)

    Exercise: $3.20From: 2003-07-03Exp: 2013-06-03→ Common Stock (70,000 underlying)
    70,000

  • Stock Options (Right to buy)

    Exercise: $7.08From: 2003-02-17Exp: 2013-01-17→ Common Stock (55,000 underlying)
    55,000

  • Stock Options (Right to buy)

    Exercise: $5.14From: 2003-01-17Exp: 2012-01-17→ Common Stock (250,000 underlying)
    250,000

  • Stock Options (Right to buy)

    Exercise: $5.74From: 2002-11-30Exp: 2011-11-30→ Common Stock (100,000 underlying)
    100,000

  • Stock Options (Right to buy)

    Exercise: $2.42From: 2007-01-12Exp: 2010-01-12→ Common Stock (62,000 underlying)
    62,000

  • Common Stock

    2,000

  • Stock Options (Right to buy)

    Exercise: $0.56From: 2000-11-15Exp: 2009-12-02→ Common Stock (240,250 underlying)
    240,250

  • Stock Options (Right to buy)

    Exercise: $2.29From: 2005-06-14Exp: 2014-06-14→ Common Stock (40,000 underlying)
    40,000

  • Stock Options (Right to buy)

    Exercise: $4.50From: 2002-07-17Exp: 2011-07-17→ Common Stock (9,500 underlying)
    9,500

  • Stock Options (Right to buy)

    Exercise: $6.38From: 2002-03-01Exp: 2011-03-01→ Common Stock (28,500 underlying)
    28,500
Footnotes (1)
  • [F1]Stock options vest according to the following schedule: One fourth (1/4) of the total number of shares subject to this option shall vest 12 months after the vesting commencement date and an additional one-forty-eigths (1/48) of the total number of shares subject to the option become exercisable each one-month-period thereafter, until all such shares are exercisable.

Documents

1 file

Issuer

ALLOS THERAPEUTICS INC

CIK 0001097264

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001097264

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:13 PM ET
Size
19.0 KB
View on SEC.gov